跳至主要内容
临床试验/NCT04498078
NCT04498078已完成不适用

The Effects of Creatine Supplementation in Autism Spectrum Disorder: a Randomized Placebo-controlled Trial

University of Novi Sad, Faculty of Sport and Physical Education1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2022年1月15日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
20
试验地点
1
主要终点
Brain creatine change

研究概览

简要总结

Autism Spectrum Disorder (ASD) is accompanied by reduced levels of total creatine in right temporal-parietal junction and other brain regions of interest, and addressing this deficit by exogenous administration of creatine may have beneficial effects on brain metabolism and disease-specific clinical symptoms in patients suffering from ASD.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
10 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Age 10 years and above
  • •Informed consent signed by a parent or legal guardian or legal representative
  • •Diagnostic and Statistical Manual of Mental Disorders-IV criteria for ASD.

排除标准

  • •Pregnant or nursing female patients
  • •Non-pharmacologic therapy
  • •Current diagnosis of other mental disorder

研究组 & 干预措施

Creatine

Experimental

Twenty grams per day b.i.d.

干预措施: Creatine (Dietary Supplement)

结局指标

主要结局

Brain creatine change

时间窗: Change from Baseline Brain Creatine Levels at 6 Months

Monitor change in brain creatine levels by magnetic resonance imaging

次要结局

  • Brain N-acetylaspartate change(Change from Baseline Brain N-acetylaspartate Levels at 6 Months)
  • Autism Treatment Evaluation Checklist (ATEC) score(Change from Baseline ATEC Scores at 6 Months)

研究者

发起方
University of Novi Sad, Faculty of Sport and Physical Education
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验